Extended rhythm monitoring identifies 64% of asymptomatic atrial fibrillation in patients on BTKi therapy
BTK Inhibitors Linked to Hidden Heart Rhythm Problem in Cancer Patients
This meta-analysis of 2839 patients with hematologic malignancies treated with Bruton's tyrosine kinase inhibitors (BTKi) found an overall a…
A meta-analysis of 2,839 patients found that 14% of atrial fibrillation cases during BTK inhibitor therapy had no symptoms.
BTK inhibitors do not significantly increase second primary malignancy risk in B-cell lymphoma patients
BTK inhibitors do not appear to cause second primary cancers
This meta-analysis of 9337 patients found that BTK inhibitors do not significantly increase the risk of second primary malignancies compared…
New data suggests that a common class of drugs used to treat certain blood cancers does not increase the risk of developing new cancers.
Aging impacts multiple sclerosis pathobiology by shifting inflammation toward chronic, compartmentalized neuroinflammation and neurodegeneration
New research explores how aging changes multiple sclerosis treatment
This narrative review examines the impact of aging on the immunological and neuroinflammatory microenvironment in older patients with multip…
As people age, multiple sclerosis can change from sudden flare-ups to a slow, steady progression of nerve damage.